Navigation Links
Developing an improved liposuction technique that melts fat
Date:6/18/2014

Although liposuction is one of the most common and well-established cosmetic surgery procedures in the U.S., it still has its drawbacks. But a new biomedical start-up says it may have found a novel way to improve the procedure using gold nanoparticles to literally melt fat, reports Chemical & Engineering News (C&EN), the weekly news magazine of the American Chemical Society.

Lauren K. Wolf, an associate editor at C&EN, explains that during the most common type of liposuction procedure, a surgeon inserts a sharp-edged needle through an incision, moves it back and forth to break up fat cells and then vacuums them out. The problem is the procedure isn't selective, and sometimes connective tissue and nerves get removed along with the fat cells. Liposuction patients often suffer from bruising, long recovery times and lumpiness that has to be corrected with a second procedure. To address the surgery's problems, a nanomedicine expert and her brother, who is a plastic and reconstructive surgeon, teamed up to try a different approach.

The duo, Adah and Khalid Almutairi, drew on some of the latest research looking into gold nanoparticles' ability to destroy cancer cells when exposed to infrared light. They wondered whether they could inject the same material into liposuction patients, light up selected areas with an infrared beam to melt the fat rather than mechanically breaking it up, and then suction out the cells. Fat melts at a low enough temperature that connective tissue and nerve cells could be spared damage, they say. A new firm, eLux Medical, has licensed the technique, now called NanoLipo. Animal trials are currently underway, and human clinical studies could begin later this year, the company says.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Toxic computer waste in the developing world
2. Resveratrol supplements cause pancreatic problems in developing fetus
3. Smokers with gene defect have 1 in 4 chance of developing lung cancer
4. Research details how developing neurons sense a chemical cue
5. New discovery: Molecule links asthma and cancer and could aid in developing new treatments
6. New towns going up in developing nations pose major risk to the poor
7. Identified epigenetic factors associated with an increased risk of developing cancer
8. Pharmocogenomics has not fulfilled its promise to developing countries
9. Where do you start when developing a new medicine?
10. How developing sperm stick to the right path
11. Advance toward developing an oral pain reliever derived from debilitating snail venom
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/2/2015)... , April 2, 2015 ... Q1 2015 attributed to somewhat higher than 125 MSEK. ... the year-end report 2014 that revenues for Q1 2015 ... the company reported for Q4 2014. The operating result ... be negative. The complete interim report will as previously ...
(Date:3/31/2015)... March 31, 2015  Elephant Talk Communications Corp. (NYSE ... provider of Software Defined Network Architecture (ET Software DNA® ... revenue of approximately $20.4 million for the year ended ... million for the year ended December 31, 2013. ... Company had completed its multi-year transition away from its ...
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... of the "Global Iris Recognition Market 2015-2019" ... the Global Iris Recognition market to grow at a ... This report covers the present scenario and the ... the period 2015-2019. To calculate the market size, the ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... Following an agreement between ESA, Krunichev Space Centre and ... and a secondary payload, the technology demonstrator Proba-2 satellite, ... new November launch date follows a rescheduling of the ... Moisture and Ocean Salinity (SMOS) satellite and the secondary ...
... heat shock protein 90 gets steroid receptors into shape ... to targeted therapies for hormone-driven cancers, such as breast ... of Georgia researchers say. "We are trying to ... conformation so they work," says Dr. Ahmed Chadli, biochemist ...
... In the fruit fly,s developing brain, stem cells called ... cell that has a different fate. But neuroblast growth can ... Researchers at Duke-NUS Graduate Medical School in Singapore ... a counterpart in mammals, that can apparently prevent brain tumors ...
Cached Biology News:SMOS and Proba-2 launch rescheduled for November 2Targeting helpers of heat shock proteins could help treat cancer, cardiovascular disease 2Tumor suppressor gene in flies may provide insights for human brain tumors 2
(Date:4/20/2015)... April 20, 2015   Meditope Biosciences, Inc ., ... proprietary technology, today announced presentation of data demonstrating the ... of antibody-drug conjugates (ADCs). The data were presented in an ... April 18-22 in Philadelphia . ... which point to the many commercial applications that may ...
(Date:4/17/2015)... April 17, 2015  Centrillion Technologies, a ... grant from the National Human Genome Research ... Health (NIH). The grant will help fund ... development of breakthrough genomic technologies, including phased ... substrates. Centrillion has been developing this transformative ...
(Date:4/17/2015)... , April 17, 2015  Guggenheim Securities, the ... today announced the hiring of William Tanner ... Mr. Tanner will start work at Guggenheim ... York office. "Bill brings a ... research, to our experienced and highly acclaimed healthcare team," ...
(Date:4/17/2015)... BellBrook Labs announced today that they ... powerful Orthogonal Pooled Screening (OPS) Platform developed and ... Lankenau Institute for Medical Research (LCGC) in Wynnewood, ... successful drug discovery outcomes using far more efficient ... available nowhere else, coupled to a state-of-the-art compound ...
Breaking Biology Technology:Meditope Biosciences Presents Data At The American Association Of Cancer Research (AACR) Annual Meeting Validating Its SnAP Technology Platform 2Guggenheim Securities Hires Biotech Analyst William Tanner in Expansion of Healthcare Coverage 2BellBrook Labs and Lankenau Institute Partner to Accelerate Drug Discovery using Orthogonal Pooled Screening 2
... Doug Valentine aka "DoctorLoopy" Wins Grand Prize with One-of-a-kind Video ... Viewers Watched and Voted for the Best Video Response to: "What Do ... The National Park Foundation and Olympus ... teacher from Melissa, TX, is the grand prize winner of the " ...
... ... and cGMP manufacturer, announced that the company is in the initial phases of a ... Pharmaceutical Ingredient (API) manufacturing facility located in Riverview, Michigan. Expansions will include a new ... ...
... ... with the first PDSS Leadership Award at the 3rd Annual Pacific Drug Safety Summit, which ... outcomes researcher, was the moderator of the event and serves as Chairman of BioSoteria,s Board ... Emeryville, CA ...
Cached Biology Technology:The National Park Foundation and Olympus Announce Winner of the First-Ever 'Your Parks' Video Challenge 2The National Park Foundation and Olympus Announce Winner of the First-Ever 'Your Parks' Video Challenge 3The National Park Foundation and Olympus Announce Winner of the First-Ever 'Your Parks' Video Challenge 4Ash Stevens Plans $6 Million Facility Expansion to Bolster CMC Capabilities 2Hugh Tilson Receives Leadership Award at Pacific Drug Safety Summit 2Hugh Tilson Receives Leadership Award at Pacific Drug Safety Summit 3
RNA polymerase sigma 70 Immunogen: Recombinant, full length protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Anti-Dardarin Immunogen: Synthetic peptide from rat LRRK2. Available Date: 38814...
Rat monoclonal to UGGT ( Abpromise for all tested applications)....
... to MSY2/YBOX2 ( Abpromise for ... Antigen: Synthetic peptide derived from ... of Human MSY2/YBOX2. (Note: the ... (Peptide available as ...
Biology Products: